Trials / Completed
CompletedNCT02710240
Indocyanine Green for Central Nervous System Tumors
A Pilot/Feasibility Study of Intraoperative Image-Guided Surgery of CNS Tumors With Indocyanine Green and MR Spectroscopic Imaging
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 336 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a single center, open-label, two-part study to assess image guided surgery of intramolecular imaging in nervous system tumors. Subjects with a diagnosis of a resectable nervous system tumor who are at risk of recurrence are included. The primary goal is to observe what tissues fluoresce in the OR, and then to identify if that tissue is cancerous/tumor or normal when the histopathology is performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indocyanine Green (ICG) | |
| RADIATION | Intraoperative near-infrared (NIR) |
Timeline
- Start date
- 2015-06-10
- Primary completion
- 2020-02-04
- Completion
- 2020-04-02
- First posted
- 2016-03-16
- Last updated
- 2021-10-27
- Results posted
- 2021-10-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02710240. Inclusion in this directory is not an endorsement.